Michelle A. Ozbun

9.2k total citations
47 papers, 2.6k citations indexed

About

Michelle A. Ozbun is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Michelle A. Ozbun has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 23 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Michelle A. Ozbun's work include Cervical Cancer and HPV Research (28 papers), Virus-based gene therapy research (11 papers) and Molecular Biology Techniques and Applications (9 papers). Michelle A. Ozbun is often cited by papers focused on Cervical Cancer and HPV Research (28 papers), Virus-based gene therapy research (11 papers) and Molecular Biology Techniques and Applications (9 papers). Michelle A. Ozbun collaborates with scholars based in United States, Italy and China. Michelle A. Ozbun's co-authors include Craig Meyers, Samuel K. Campos, Zurab Surviladze, Jessica L. Smith, Rosa T. Sterk, Janet S. Butel, Lawrence Banks, Michael P. Myers, Paul F. Lambert and Lanlan Wei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Michelle A. Ozbun

47 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle A. Ozbun United States	31	1.5k	1.0k	605	590	488	47	2.6k
Luise Florin Germany	27	1.3k 0.9×	923 0.9×	727 1.2×	674 1.1×	370 0.8×	49	2.6k
Lynn R. Budgeon United States	31	1.4k 0.9×	688 0.7×	654 1.1×	462 0.8×	440 0.9×	72	2.6k
Robert Ralston United States	37	1.9k 1.3×	1.8k 1.7×	597 1.0×	823 1.4×	655 1.3×	78	4.8k
Elizabeth White United States	27	1.1k 0.7×	963 0.9×	430 0.7×	265 0.4×	637 1.3×	61	2.4k
Elisabeth Schwarz Germany	17	1.2k 0.8×	1.2k 1.2×	352 0.6×	587 1.0×	499 1.0×	35	2.4k
Aldo Venuti Italy	35	1.6k 1.1×	1.2k 1.1×	802 1.3×	470 0.8×	824 1.7×	137	3.8k
Sheila V. Graham United Kingdom	36	1.6k 1.1×	1.7k 1.6×	568 0.9×	362 0.6×	346 0.7×	91	3.2k
Ann Roman United States	26	1.5k 1.0×	1.0k 1.0×	523 0.9×	488 0.8×	776 1.6×	61	2.7k
Thomas R. Broker United States	30	2.1k 1.4×	1.4k 1.3×	549 0.9×	977 1.7×	762 1.6×	57	3.2k
Heather Griffin United Kingdom	25	1.7k 1.1×	693 0.7×	473 0.8×	275 0.5×	511 1.0×	37	2.3k

Countries citing papers authored by Michelle A. Ozbun

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Ozbun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Ozbun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Ozbun more than expected).

Fields of papers citing papers by Michelle A. Ozbun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Ozbun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Ozbun. The network helps show where Michelle A. Ozbun may publish in the future.

Co-authorship network of co-authors of Michelle A. Ozbun

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Ozbun. A scholar is included among the top collaborators of Michelle A. Ozbun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Ozbun. Michelle A. Ozbun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sterk, Rosa T., et al.. (2023). The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis. Antiviral Research. 216. 105667–105667. 2 indexed citations

Sterk, Rosa T., Joon‐Yong Chung, Kiersten L. Berggren, et al.. (2021). MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors. PLoS Pathogens. 17(1). e1009216–e1009216. 25 indexed citations

Ozbun, Michelle A. & Samuel K. Campos. (2021). The long and winding road: human papillomavirus entry and subcellular trafficking. Current Opinion in Virology. 50. 76–86. 27 indexed citations

Ozbun, Michelle A., Rosa T. Sterk, Alan G. Waxman, et al.. (2021). Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants. EBioMedicine. 63. 103165–103165. 14 indexed citations

Ozbun, Michelle A., Rosa T. Sterk, Alan G. Waxman, et al.. (2020). Infectious Titres of Human Papillomaviruses (HPVs) in Patient Lesions, Methodological Considerations in Evaluating HPV Infectivity and Implications for the Efficacy of High-Level Disinfectants. SSRN Electronic Journal. 1 indexed citations

Ozbun, Michelle A.. (2019). Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry. Papillomavirus Research. 7. 188–192. 26 indexed citations

Ozbun, Michelle A., et al.. (2019). The Known and Potential Intersections of Rab-GTPases in Human Papillomavirus Infections. Frontiers in Cell and Developmental Biology. 7. 139–139. 18 indexed citations

Brand, Toni M., Stefan Hartmann, Neil E. Bhola, et al.. (2018). Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 78(9). 2383–2395. 31 indexed citations

Muñoz, Juan P., Gloria M. Calaf, Óscar León, et al.. (2018). Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells. Frontiers in Microbiology. 9. 3022–3022. 40 indexed citations

10.

Berggren, Kiersten L., Sebastián Cruz-Gómez, Alexis J. Cowan, et al.. (2018). Inhibition of MK2 Decreases Inflammatory Cytokine Production and Tumor Volumes in HPV-Positive and HPV-Negative Models of Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1372–1373. 2 indexed citations

11.

Surviladze, Zurab, et al.. (2015). Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection. Journal of General Virology. 96(8). 2232–2241. 45 indexed citations

12.

Wei, Lanlan, et al.. (2014). Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis. 35(10). 2373–2381. 36 indexed citations

13.

Surviladze, Zurab, et al.. (2012). Essential Roles for Soluble Virion-Associated Heparan Sulfonated Proteoglycans and Growth Factors in Human Papillomavirus Infections. PLoS Pathogens. 8(2). e1002519–e1002519. 148 indexed citations

14.

Wei, Lanlan, et al.. (2009). Nitric Oxide Induces Early Viral Transcription Coincident with Increased DNA Damage and Mutation Rates in Human Papillomavirus–Infected Cells. Cancer Research. 69(11). 4878–4884. 79 indexed citations

15.

Moseley, Pope, et al.. (2009). Inducible heat shock protein 70 enhances HPV31 viral genome replication and virion production during the differentiation-dependent life cycle in human keratinocytes. Virus Research. 147(1). 113–122. 18 indexed citations

16.

Smith, Jessica L., Diane S. Lidke, & Michelle A. Ozbun. (2008). Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix. Virology. 381(1). 16–21. 59 indexed citations

17.

Tomaić, Vjekoslav, Daniela Gardiol, Paola Massimi, et al.. (2008). Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene. 28(1). 1–8. 63 indexed citations

18.

Smith, Jessica L., et al.. (2005). Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate. Journal of Virology. 79(11). 6838–6847. 56 indexed citations

19.

Lambert, Paul F., et al.. (2005). Using an Immortalized Cell Line to Study the HPV Life Cycle in Organotypic. Humana Press eBooks. 119. 141–156. 59 indexed citations

20.

Ozbun, Michelle A. & Craig Meyers. (1998). Human Papillomavirus Type 31b E1 and E2 Transcript Expression Correlates with Vegetative Viral Genome Amplification. Virology. 248(2). 218–230. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact